A Pharmacodynamic Study With Ticagrelor in African American Patients

NCT01523392 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Stable Coronary Artery Disease

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel

Sponsor

AstraZeneca